SNOA

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) is a specialty pharmaceutical company founded in 1999 and originally incorporated as Oculus Innovative Sciences before rebranding in December 2016. Based in Woodstock, Georgia, the company has developed a unique focus on stabilized hypochlorous acid (HOCl) technology for medical and healthcare applications. Since going public in 2007, Sonoma has built a portfolio of HOCl-based products spanning wound care, dermatology, eye care, oral care, and animal health markets across the United States, Latin America, Europe, and other international markets.